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A B S T R A C T
The aim of this study was to evaluate macular thickness parameters in glaucoma patients and to compare them to
normal subjects using Optical Coherence Tomography (OCT). This prospective, observational study included 20 primary
open angle glaucoma patients (POAG) and 20 healthy subjects in control group. Exclusion criteria were diabetes and
other macular pathology, like age-related macular degeneration, macular oedema, central serous retinopathy and high
myopia >4.00 dsph. OCT imaging of peripapillar retina and macular area were performed using Cirrus HD OCT. In
these two groups of patients we analyzed changes of macular thickness parameters (central subfield thickness, macular
volume, and average macular thickness). The group of glaucoma patients had decreased values of the two macular thick-
ness parameters: macular volume and average macular thickness, compared to control group. There was no difference in
central macular thickness, presumably because of the absence of the ganglion cells in this layer. Macular imaging can be
a useful additional method to determine glaucoma status and has a potential for tracking glaucoma progression.
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Introduction
Glaucoma is a multifactorial optic nerve neuropathy
characterized by a loss of retinal ganglion cells with re-
sult in visual function impairment. It is diagnosed clini-
cally by observing optic disc changes and by measure-
ment of visual function with perimetry. Although peri-
metry and optic nerve cupping are subjective examina-
tions and can be variously interpreted, they have the ad-
vantage of providing a topographical spatial representa-
tion of the visual loss, which can be compared to charac-
teristic patterns of glaucomatous loss1.
In addition to these diagnostic procedures, clinicians
nowadays also use images from optical coherence tomog-
raphy (OCT). OCT has been shown to be a useful tool for
diagnosing and evaluating glaucoma, based on measure-
ment of optic nerve and peripapillary retina as well as
macular thickness parameters2,3.
The macula contains over 50% of all retinal ganglion
cells (RGCs) and is an ideal area for early detection of cell
loss and changes over time because of high cell density.
In the macular area ganglion cells are arranged in 4–6
layers making up 30% to 35% of retinal macular thick-
ness, so that the loss of macular ganglion cells results in
significant retinal or retinal nerve fibre layer (RNFL)
thinning. Several studies indicated that in glaucomatous
eyes decreases in macular thickness and volume are due
to loss of RGCs and that this findings correlate with
RNFL thickness and visual field defects2,4–8. Recent stud-
ies imply that thinning of RNFL is related to thinning of
macular ganglion cell complex (GCC), which is defined as
three innermost retinal layers: 1) RNFL (made of gan-
glion cell axons), 2) ganglion cell layer (GCL) made of
ganglion cell bodies and 3) the inner plexiform layer
(IPL) made out of ganglion cell dendrites. All three lay-
ers of ganglion cells complex are significantly thinner in
glaucoma patients, reflecting the proportion of dead gan-
glion cells8, although Tan et al. found that residual glial
tissue maintains 50% thickness even when nearly all
ganglion cells were lost9.
441
Received for publication February 5, 2012
At the time of this writing, only with the RTVue Fou-
rier domain (fd) OCT system (Optovue, Inc., Fremont
CA) and upgraded version of Cirrus HD OCT was possi-
ble to measure the thickness of the two layers damaged
by glaucoma, RNFL, which contains the axons of the
RGCs, and the RGC plus IPL, which contains the RGC
bodies as well as the connections of the cells of the inner
nuclear layer to RGCs10. We have measured central sub-
field thickness, macular volume and average macular
thickness with standard Cirrus HD OCT to evaluate the
macular thickness in glaucomatous and normal eyes and
to evaluate correlation of macular volume with the glau-
coma status.
Materials and Methods
Our study included 40 eyes: 20 with glaucoma and 20
healthy subjects examined between January 2011 and
July 2011 at the University of Zagreb, »Sestre milosrd-
nice« University Hospital Center, Department of Oph-
thalmology, Zagreb, Croatia. Informed consent was ob-
tained from each participant before enrolment. Glaucoma
participants (11 male and 9 female, mean age of 69.5
y±3.4) included patients with primary open-angle glau-
coma (POAG). Twenty healthy participants (10 male and
10 female, with a mean age of 60.5 y±6.6) were also in-
cluded in the study.
All glaucoma patients had undergone a complete oph-
thalmologic examination. This consisted of the following:
medical history (including ocular and family histories),
best corrected visual acuity (BCVA), slit lamp examina-
tion, intraocular pressure (IOP) measurement using Gold-
mann applanation tonometry, gonioscopy, dilated fundus
biomicroscopy using 78-diopter lens, and Octopus dG2
visual field testing. Each patient had a diagnosis of
POAG, based on glaucomatous damage to the optic disc
(optic nerve head cupping) and abnormal visual field
with controlled IOP values (21 mmHg) on topical mono-
therapy or combined two hypotensive medications. All
eyes with glaucoma had associated visual field loss (mean
defect of 3.0–15.0 dB) in at least 2 consecutive examina-
tions tested by the Octopus 900 visual field analyser. Ex-
clusion criteria included diabetic retinopathy, macular
degeneration, macular oedema, epiretinal membrane, re-
tinal detachment, cataract, high myopia (greater than –
4.00 dsph or 2.00 dcyl), presence of nonglaucomatous op-
tic nerve diseases and previous ocular surgery or trauma.
We have also excluded all patients with secondary glau-
coma, chronic angle closure glaucoma and POAG treated
surgically or by laser treatment, as well as the patients
with BCVA 0.5 according to Snellen.
The control group included subjects with no history of
glaucoma or retinal pathology, IOP<21 mm Hg, normal
optic nerve head appearance, and normal visual field
testing results (mean defect –2.0 – +2.0 dB). Normal eyes
served as the control group.
All patients were scanned with Cirrus HD OCT, ac-
cording to the manufacturer instructions, including im-
aging of peripapillary retina and macular area. We ana-
lysed changes of macular thickness parameters: central
subfield thickness, macular volume and average macular
thickness together with peripapillary retinal nerve fibre
layer measurements. The borderline of RNFL values in
control group was set at 80 mm according to Cirrus
HD-OCT RNFL normative database11. In addition, we
have divided glaucoma group of patients in two catego-
ries setting arbitrarily border of RNFL thickness at 53 mm,
to be able to better distinguish the correlation between
the RNFL thickness and macular volume parameters.
Statistical analysis was made using Mann Whitney´s
test. A p value of 0.05 or less was considered to be statis-
tically significant.
The study protocol adheres to the principles of the
Declaration of Helsinki and was approved by the Institu-
tional Review Board of the »Sestre milosrdnice« Univer-
sity Hospital Center, Department of Ophthalmology, Zag-
reb, Croatia.
Results
We have investigated 40 eyes, 20 glaucoma patients
and 20 normal subjects. Values of peripapillary RNFL
and macular thickness parameters were compared in two
examined groups (Table 1 and Table 2).
We observed significant changes in macular thickness
parameters (macular volume and average macular thick-
ness) in glaucomatous patients group, (p<0.001), while
there were no changes in central macular thickness val-
ues. Normal eyes had significantly greater macular vol-
ume than subjects with advanced glaucoma (p<0.001).
In this group we found 6 patients with RNFL less than
80 mm (range 74–78 mm) (Table 2). The X±SD macular
volume for glaucomatous eyes was 9.0±0.7 and for nor-
mal eyes was 9.9±0.4 (Table 3).
We have divided glaucoma patients in two groups –
those with retinal thickness <53mm and those 53mm.
Table 4 gives values of peripapillary RNFL and macular
thickness parameters in these two groups.
Discussion
Structural changes in glaucoma are manifested by
thinning of RNFL, that may be used as an early marker
to identify risk of progression of visual field defect, al-
though histopathological studies imply that up to 40% of
axonal loss could be lost before visual field defects are
detected12–14.
The studies have shown correlation between macular
parameters and glaucoma status2,4–8,15. Zeimer et al. first
observed a relationship between macular thickness and
glaucomatous damage, based on prior animal studies in
which primate models of glaucoma demonstrated a sig-
nificant loss of RGCs in the perifoveal region4,16. To con-
firm Zeimer’s hypothesis Lederer et al. evaluated macu-
lar volume in normal, glaucoma suspect, and glaucoma-
tous subjects using a time domain optical coherence to-
mography (TD-OCT)15. Their results demonstrated a sig-
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nificant correlation between macular volume and glaucoma
status with decreased macular volume in patients with
more advanced disease as well as significant difference of
macular volume between normal and glaucomatous eyes.
OCT tomograms present volumetric analysis of ma-
cular thickness and some studies indicated that they may
be useful method of documenting and monitoring pa-
tients with early and advanced glaucoma6. To test this,
we investigated 20 glaucoma patients and 20 controls us-
ing Cirrus HD OCT. In these two groups of examinees we
analyzed changes of macular thickness parameters (cen-
tral subfield thickness, macular volume, and average
macular thickness).
Our results show a significant correlation between
macular volume, average macular thickness and advan-
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TABLE 1
PERIPAPILLARY RNFL AND MACULAR THICKNESS
PARAMETERS IN GLAUCOMA PATIENTS
Glaucoma patients
Peripapillar
RNFL mm CMT mm
V mm³ AMT mm
79 263 10.1 279
48 264 9.2 257
58 211 7.8 216
60 270 9.2 256
53 290 9.2 255
40 276 9.5 263
52 247 8.1 224
71 285 9.5 265
70 254 9.9 274
58 234 8.3 230
66 233 9.7 267
68 266 9.6 276
52 264 9.2 255
79 265 10.0 280
50 248 8.8 245
46 251 7.8 216
60 263 9.0 249
70 280 9.3 259
35 266 8.6 238
50 259 8.1 225
RNFL – retinal nerve fibre layer, CMT – central macular thick-
ness, V – macular volume, AMT – average macular thickness;
values 53 mm are marked in bold.
TABLE 2
PERIPAPILLARY RNFL AND MACULAR THICKNESS
PARAMETERS IN CONTROL GROUP
Control group
Peripapillar
RNFL mm CMT mm
V mm³ AMT mm
90 269 10.0 294
93 268 10.4 289
80 273 9.4 260
74 242 9.5 262
78 289 9.4 260
80 278 9.4 261
82 256 9.9 280
83 249 9.9 279
77 257 9.9 273
75 249 9.3 258
99 303 9.5 263
97 295 9.6 267
86 265 10.4 289
77 258 9.9 275
78 256 10.1 280
86 243 9.9 274
95 267 10.1 281
89 234 9.9 276
92 287 10.7 305
85 267 10.1 280
RNFL – retinal nerve fibre layer, CMT – central macular thick-
ness, V – macular volume, AMT – average macular thickness;
RNFL values<80 mm are marked in bold.
TABLE 3
PERIPAPILLARY RNFL VALUES AND MACULAR THICKNESS
PARAMETERS IN GLAUCOMA PATIENTS AND IN CONTROLS
Glaucoma patients Controls
U p
X SD X SD
RNFL mm 60.9 ±15.2 84.8 ±7.6 38 <0.001
CMT mm 259.5 ±18.7 265.3 ±18.4 170 0.429
Vmm3 9.0 ±0.7 9.9 ±0.4 63 <0.001
AMT mm 251.4 ±20.5 275.3 ±12.8 64.5 <0.001
RNFL – retinal nerve fibre layer, CMT – central macular thick-
ness, V – macular volume, AMT – average macular thickness, X
– mean, SD – standard deviation, Mann Whitney's U-test, p – p
value
TABLE 4
PERIPAPILLARY RNFL AND MACULAR THICKNESS
PARAMETERS IN GLAUCOMA PATIENTS
RNFL<53 mm RNFL >53 mm
U p
X SD X SD
V mm³ 8.7 ±0.6 9.3 ±0.7 22.5 0.038
AMT mm 241.0 ±17.0 259.1 ±20.5 21.5 0.031
RNFL – retinal nerve fibre layer, CMT – central macular thick-
ness, V – macular volume, AMT – average macular thickness, X
– mean, SD – standard deviation, Mann Whitney´s U-test, p – p
value
ced glaucoma status, with decreased values in patients
with more advanced disease. Central macular thickness
values did not change with the progression of glaucoma
disease, presumably reflecting the absence of the gan-
glion cells in this layer.
Our study confirms that macular volume can be use-
ful indicator for evaluating glaucoma status and glau-
coma progression. Patients with RNFL <53 mm had thin-
ner macular volume and average macular thickness com-
pared to patients with RNFL 53.
It is of interest to notice that 6 patients in the normal
group had RNFL less than 80 mm with no clinical or
perimetric signs of the disease. These patients subse-
quently underwent a complete ophthalmologic examina-
tion and we excluded preperimetric glaucoma or optic
neuropathy due to other causes. The follow up of these
patients will continue in order to detect eventual appear-
ance of preperimetric glaucoma or other nonglaucoma-
tous optic neuropathy allowing timely treatment if in-
dicated17. The limitations of our study are small sample
size and elderly age of examinees that could correlate
with macular pathology which is sometimes difficult to
exclude entirely by clinical examination. Additionally,
OCT imaging of the optic nerve, peripapillary RNFL,
macular volume and macular thickness may be limited
by signal quality and image artefact18,19.
Several studies compared diagnostic ability of RNFL
thickness using Time Domain and Spectral Domain OCT.
SD-OCT presented higher diagnostic ability for preperi-
metric glaucoma20–22. Schuman showed that SD-OCT
had better reproducibility in both peripapillary RNFL
and macular scan thickness measurements over the TD-
-OCT, primarily for sectoral measurements which is im-
portant in earlier stage of glaucoma23. Studies using
RTVue Fourier domain (fd) OCT system that has the
ability to measure GCC have observed that thickness of
this complex correlates best with the progression of glau-
coma and visual field changes24–27. Tan et al. also pointed
out that the outer retina which takes up to 65–70% of to-
tal retinal thickness is not much affected by glaucoma,
and that isolated GCC measurement from the outer ret-
ina enhances our ability to discriminate between healthy
and glaucomatous eyes.
According to Tan et al., although GCC and average
RNFL parameters perform similarly in terms of glau-
coma diagnosis, the GCC is more reproducible and there-
fore may be better for accurate tracking of glaucomatous
progression. In their study, combining GCC parameters
with standard RNFL parameters significantly increased
the detection rate of both preperimetric and perimetric
glaucoma. They found that GCC information added to
RNFL thickness data increased the sensitivity of detec-
tion from 78% to 87% in the perimetric glaucoma group
and from 45% to 56% in the group of pre-perimetric re-
spondents 9. The best GCC diagnostic parameters were
focal volume and global loss of volume, both of which
measure deviations from the normal pattern of GCC
thickness.
Authors Moreno et al. also suggested that the GCC
scan is showing a similar or even a slightly better ability
to discriminate between healthy and early glaucomatous
eyes compared to the peripapillary RNFL scan. There-
fore, the authors conclude that the GCC macular scan is
a useful tool for identification of early structural damage
in patients with glaucoma28.
Although we were not able to perform GCC measure-
ment, we have clearly shown the correlation between
RNFL thickness, macular volume parameters and glau-
coma progression, confirming that measurement of any
of these parameters is useful in follow up of glaucoma pa-
tients, regardless of the available equipment.
Further development of the Cirrus 6.0 software with
the possibility of analysis of the complex ganglion cell-in-
ner plexiform layer (GCIPL) will become available in
future29.
Ahmad et al. further suggested that newer OCT soft-
ware algorithms will combine RNFL, optic nerve head,
and GCC parameters to further increase diagnostic OCT
spectrum as well as to provide faster, easier and more ac-
curate monitoring of disease progression30.
In conclusion, our study shows that macular volume
can be a valuable indicator of glaucoma status, starting
from early stages. For the measurement of this useful,
objective and quantitative parameter for evaluating glau-
coma disease progression we have different available
technologies that are continuously improving. Further
follow up of progression of changes in RNFL and ma-
cular thickness in asymptomatic patients is needed to es-
tablish their diagnostic and prognostic significance.
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MJERENJE DEBLJINE I VOLUMENA MAKULARNOG PODRU^JA OPTI^KOM KOHERENTNOM
TOMOGRAFIJOM U SVRHU PRA]ENJA PROGRESIJE GLAUKOMSKE BOLESTI
S A @ E T A K
Cilj ovog ispitivanja bio je utvrditi debljinu makule kod bolesnika s glaukomom te je usporediti s kontrolnom sku-
pinom zdravih osoba koriste}i Opti~ku Koherentnu Tomografiju (OCT). Ova prospektivna, opservacijska studija uklju-
~uje 20 bolesnika s glaukomom otvorenog kuta i kontrolnu skupinu koju ~ini 20 osoba bez glaukoma. U ispitivanje
nismo uklju~ili bolesnike koji su imali dijabeti~ku i druge makulopatije, senilnu makularnu degeneraciju, makularni
edem, centralnu seroznu retinopatiju i miopiju >4,00 dsph. Makularno podru~je i peripapilarna debljina `iv~anih niti
snimljeni su Cirrusovim HD OCT-om. U ove dvije skupine ispitanika analizirali smo promjene u debljini makule (cen-
tralnu debljinu, makularni volumen i prosje~nu debljinu makule). Pokazalo se da grupa bolesnika s glaukomom ima
smanjenu vrijednost makularnih parametara u usporedbi sa kontrolnom skupinom, dok nije bilo razlike u debljini
centralnog dijela makule. Studija pokazuje da analiza debljine makularnog podru~ja mo`e biti korisna dodatna metoda
za odre|ivanje statusa i pra}enja progresije glaukomske bolesti.
F. Bari{i} et al.: Macular Thickness and Volume Parameters in Glaucoma, Coll. Antropol. 36 (2012) 2: 441–445
445
